Continuous monitoring of biochemical messengers using advanced assays
Online Affinity Micro Free Flow Electrophoresis Assays for Continuous Monitoring of Biochemical Messengers
['FUNDING_R01'] · UNIVERSITY OF MINNESOTA · NIH-11072119
This study is working on a new tool that can watch how cells release important signals in real time, which could help doctors better understand and treat conditions like addiction and metabolic disorders.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MINNESOTA (nih funded) |
| Locations | 1 site (MINNEAPOLIS, UNITED STATES) |
| Trial ID | NIH-11072119 on ClinicalTrials.gov |
What this research studies
This research aims to develop a new type of assay that can continuously monitor the release of biochemical messengers from living cells in real time. By integrating microfluidics with affinity reagents, such as antibodies, the researchers will create a system that allows for the dynamic analysis of these messengers, overcoming the limitations of traditional static assays. Patients may benefit from this technology as it could lead to better understanding and treatment of conditions related to biochemical signaling, such as addiction and metabolic disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions influenced by biochemical messengers, such as addiction or metabolic disorders.
Not a fit: Patients who do not have conditions related to biochemical signaling may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with more accurate and timely monitoring of biochemical changes related to their conditions.
How similar studies have performed: Other research has shown promise in using microfluidic technologies for real-time monitoring, suggesting that this approach could be effective.
Where this research is happening
MINNEAPOLIS, UNITED STATES
- UNIVERSITY OF MINNESOTA — MINNEAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BOWSER, MICHAEL T — UNIVERSITY OF MINNESOTA
- Study coordinator: BOWSER, MICHAEL T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: addictive disorder